1. Home
  2. EXP vs RGEN Comparison

EXP vs RGEN Comparison

Compare EXP & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eagle Materials Inc

EXP

Eagle Materials Inc

N/A

Current Price

$216.53

Market Cap

7.2B

Sector

Industrials

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$167.05

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXP
RGEN
Founded
1963
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
8.2B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
EXP
RGEN
Price
$216.53
$167.05
Analyst Decision
Hold
Buy
Analyst Count
8
10
Target Price
$236.25
$174.90
AVG Volume (30 Days)
442.9K
701.7K
Earning Date
01-28-2026
10-28-2025
Dividend Yield
0.46%
N/A
EPS Growth
N/A
N/A
EPS
13.52
0.03
Revenue
$2,301,796,000.00
$707,890,000.00
Revenue This Year
$2.81
$17.84
Revenue Next Year
$3.96
$12.57
P/E Ratio
$16.09
$6,381.36
Revenue Growth
1.50
11.74
52 Week Low
$191.91
$102.97
52 Week High
$265.42
$182.52

Technical Indicators

Market Signals
Indicator
EXP
RGEN
Relative Strength Index (RSI) 43.95 59.19
Support Level $215.30 $156.01
Resistance Level $226.83 $165.02
Average True Range (ATR) 5.67 4.67
MACD -0.48 -0.53
Stochastic Oscillator 0.00 73.38

Price Performance

Historical Comparison
EXP
RGEN

About EXP Eagle Materials Inc

Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: